Status:

UNKNOWN

Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness

Lead Sponsor:

Bispebjerg Hospital

Conditions:

Telangiectasis

Erythema

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of the study is to compare efficacy and adverse effects of pulsed dye laser and intense pulsed light in patients with skin telangiectasia and redness.

Eligibility Criteria

Inclusion

  • 18 years or older
  • Skin types I, II, III
  • No previous laser or IPL treatment for the condition

Exclusion

  • Younger than 18 years old
  • Skin types IV, V, or VI
  • Pregnant or lactating women
  • Previous laser or IPL treatment for the condition
  • Recent exposure to sun or sun-beds
  • Treatment with oral retinoid within 6 months
  • Tendency to produce hypertrophic scars or keloids

Key Trial Info

Start Date :

February 1 2005

Trial Type :

INTERVENTIONAL

End Date :

August 1 2005

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00206921

Start Date

February 1 2005

End Date

August 1 2005

Last Update

July 25 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Bispebjerg Hospital

Copenhagen, Copenhagen NV, Denmark, 2400